Bepotastine Besilate Ophthalmic Solution 1.5% Produces Strong Clinical Benefit for Ocular Itching Immediately Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

American Journal of Ophthalmology ◽

10.1016/s0002-9394(00)00689-9 ◽

2000 ◽

Vol 130 (6) ◽

pp. 717-723 ◽

Cited By ~ 18

Author(s):

Peter A Netland ◽

Charles Leahy ◽

Kathleen L Krenzer

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Ophthalmic Suspension

Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis

Clinical Therapeutics ◽

10.1016/s0149-2918(08)80051-3 ◽

2008 ◽

Vol 30 (7) ◽

pp. 1272-1282 ◽

Cited By ~ 10

Author(s):

Gail L. Torkildsen ◽

Mark B. Abelson ◽

Paul J. Gomes

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Single Center ◽

Ketotifen Fumarate ◽

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

Clinical Ophthalmology ◽

10.2147/opth.s185835 ◽

2018 ◽

Vol Volume 12 ◽

pp. 2617-2628 ◽

Cited By ~ 4

Author(s):

Edward Meier ◽

Gail Torkildsen ◽

Paul Gomes ◽

Mark C. Jasek

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Phase Iii ◽

Phase Iii Trials ◽

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Current Eye Research ◽

10.1080/02713680701736558 ◽

2007 ◽

Vol 32 (12) ◽

pp. 1017-1022 ◽

Cited By ~ 11

Author(s):

Mark B. Abelson ◽

Dennis L. Spangler ◽

Arthur B. Epstein ◽

Francis S. Mah ◽

H. Jerome Crampton

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Once Daily ◽

Ocular Itching ◽

Evaluation of Comfort Using Olopatadine Hydrochloride 0.1% Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Contact Lens Wearers Compared to Placebo Using the Conjunctival Allergen-Challenge Model

Eye & Contact Lens Science & Clinical Practice ◽

10.1097/01.icl.0000063576.32087.f7 ◽

2003 ◽

Vol 29 (2) ◽

pp. 113-116 ◽

Cited By ~ 14

Author(s):

Miguel Brodsky ◽

William E. Berger ◽

Salim Butrus ◽

Arthur B. Epstein ◽

Murat Irkec

Keyword(s):

Contact Lens ◽

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Olopatadine Hydrochloride

Phase 3 Randomized Double-Masked Study of Efficacy and Safety of Once-Daily 0.77% Olopatadine Hydrochloride Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model

Cornea ◽

10.1097/ico.0000000000000562 ◽

2015 ◽

Vol 34 (10) ◽

pp. 1245-1251 ◽

Cited By ~ 7

Author(s):

Eugene McLaurin ◽

Abhijit Narvekar ◽

Paul Gomes ◽

Adeniyi Adewale ◽

Gail Torkildsen

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Efficacy And Safety ◽

Phase 3 ◽

Once Daily ◽

Olopatadine Hydrochloride

An Evaluation of Onset and Duration of Action of Patanol® (Olopatadine Hydrochloride Ophthalmic Solution 0.1%) Compared to Claritin® (Loratadine 10 mg) Tablets in Acute Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model

Acta Ophthalmologica Scandinavica ◽

10.1034/j.1600-0420.2000.078s230060.x ◽

2000 ◽

Vol 78 ◽

pp. 60-63 ◽

Cited By ~ 40

Author(s):

Mark B. Abelson ◽

Donna L. Welch

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Duration Of Action ◽

Olopatadine Hydrochloride

Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Tearing 16 Hours Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2010.12.1022 ◽

2011 ◽

Vol 127 (2) ◽

pp. AB257-AB257

Author(s):

J.I. Williams ◽

E.B. McLaurin ◽

F.K. Kurata ◽

M.B. Abelson ◽

J.A. Gow ◽

...

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Bepotastine Besilate Ophthalmic Solution 1.5% Reduces Nonocular Composite Symptom (NOCS) Scores 16 Hours Following Dosing in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2010.12.1016 ◽

2011 ◽

Vol 127 (2) ◽

pp. AB255-AB255

Author(s):

J.A. Gow ◽

T.T. Macejko ◽

M.T. Bergmann ◽

E. Meier ◽

M.B. Abelson ◽

...

Keyword(s):

Allergic Conjunctivitis ◽

Allergen Challenge ◽

Ophthalmic Solution ◽

Efficacy of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared With Placebo in the Conjunctival Allergen Challenge Model

Archives of Ophthalmology ◽

10.1001/archopht.121.5.626 ◽

2003 ◽

Vol 121 (5) ◽

pp. 626 ◽

Cited By ~ 17

Author(s):

Mark B. Abelson

Keyword(s):

Allergen Challenge ◽

Ophthalmic Solution ◽

Ketotifen Fumarate ◽